Previous 10 | Next 10 |
LEXINGTON, Mass., Jan. 04, 2024 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to advancing neurogenetic medicines, today announced the pricing of an underwritten public offering of 7,777,778 shares of its common stock at a public offering price o...
2024-01-04 16:26:56 ET More on Voyager Therapeutics Voyager stock surges on ~$1.3B licensing deal with Novartis for Huntington's candidate Voyager Therapeutics Non-GAAP EPS of -$0.59 beats by $0.01, revenue of $4.61M beats by $1.7M Seeking Alpha’s Quant Rating...
LEXINGTON, Mass., Jan. 04, 2024 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to advancing neurogenetic medicines, today announced that it has commenced an underwritten public offering of $100 million of shares of its common stock (or pre-f...
2024-01-03 19:51:02 ET DENVER, Colo., Jan. 3, 2024 ( www.247marketnews.com )- 24/7 Market News covered the following companies today; ABVC BioPharma, Inc. (NASDAQ: ABVC), Neximmune Inc (NASDAQ: NEXI), Sidus Space Inc (NASDAQ: SIDU), Voyager Therapeutics Inc (NASDAQ: VYGR), and Cingulate...
2024-01-03 10:00:01 ET More on Health Care Select Sector SPDR XLV Likely Back To Outperforming XLV: Considering The Low-Maintenance Option To Navigate The Healthcare Sector Covid-vaccine makers top laggard list, LLY and WST top gainers list Healthcare and uti...
LEXINGTON, Mass., Jan. 03, 2024 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to advancing neurogenetic medicines, today announced that Chief Executive Officer Alfred W. Sandrock, Jr., M.D., Ph.D., will present at the 42 nd Annual J.P. Morgan...
2024-01-02 17:52:42 ET DENVER, Colo., Jan. 2, 2024 ( www.247marketnews.com )- 24/7 Market News covered the following companies today; Longboard Pharmaceuticals Inc (NASDAQ: LBPH), Voyager Therapeutics Inc (NASDAQ: VYGR), Polished.com Inc (AMEX: POL), C4 Therapeutics Inc. (NASDAQ: CCCC),...
2024-01-02 12:56:48 ET More on Mid-day movers & stocks. ENDRA Life Sciences Inc. (NDRA) Q3 2023 Earnings Call Transcript PolyPid Ltd. (PYPD) Q3 2023 Earnings Call Transcript Seeking Alpha’s Quant Rating on Endra Life Sciences Historical earnings da...
2024-01-02 10:09:39 ET DENVER, Colo., Jan. 2, 2024 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual volume; Longboard Pharmaceuticals Inc (NASDAQ: LBPH), Voyager Therapeutics Inc (NASDAQ: VYGR), Soligenix Inc (NASDAQ: ...
2024-01-02 08:24:37 ET DENVER, Colo., Jan. 2, 2024 ( www.247marketnews.com )- Voyager Therapeutics, Inc. (NASDAQ: VYGR) reported, this morning, that it formed a strategic collaboration and capsid license agreement with a Novartis AG (NYSE: NVS) to advance potential gene therapies for Hu...
News, Short Squeeze, Breakout and More Instantly...
Voyager Therapeutics Inc. Company Name:
VYGR Stock Symbol:
NASDAQ Market:
Voyager Therapeutics Inc. Website:
LEXINGTON, Mass., May 16, 2024 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to advancing neurogenetic medicines, today announced that the first participants were dosed in a Phase 1a single ascending dose (SAD) trial of VY-TAU01, an investigation...
- Company announces clearance of IND application with FDA for anti-tau antibody VY-TAU01 for the treatment of Alzheimer’s disease; expect to begin single ascending dose trial in the coming weeks - - Development candidates selected for Neurocrine-partnered GBA1 and Friedreich ...
Aileron Therapeutics Inc. (ALRN) is expected to report for Q1 2024 DZS Inc. (DZSI) is expected to report $-0.09 for Q1 2024 Bitfarms Ltd. (BITF) is expected to report $-0.03 for Q1 2024 180 Degree Capital Corp. (TURN) is expected to report for quarter end 2024-03-31 Abacus Life In...